CAS: 2050-20-6; Diethyl Heptanedioate

相似化合物

111-16-0 33018-91-6 629-30-1

上下游产品

heptanedioic acid ethanol diethyl 1-acetylpentane-1,5-dicarboxylate pentane-1,1,5,5-tetracarboxylic acid tetraethyl ester7-ethoxy-7-oxoheptanoic acid N,N'-bis-(trans-2-hydroxy-cyclohexyl)-heptanediamideoptically inactive N,N'-bis-(trans-2-hydroxy-cyclohexyl)-heptanediamide ethyl 2-ox°Cyclohexane carboxylate 1,7-heptandiol

庚二酸置于氯化亚砜,Sodium Carbonate体系中,化学反应 5.5H,反应生成庚二酸二乙酯
参考文献:Us2014/256775
标题:Us2014/256775

专利信息

专利号:US-2006111580-A1
优先权日:2004-10-01
标 题 :Methods for the synthesis of chiral dihydroxy ketone intermediates useful for the chiral synthesis of carotenoids

专利号:US-2003089435-A1
优先权日:2000-03-23
标题:Method of synthesizing diglycerol tetranitrate, and solid rocket motor propellant containing the same
发明人：SANDERSON ANDREW J; MARTINS LAURA J
摘要:Diglyercol tetranitrate is an energetic nitrate ester plasticizer having no freezing point, making the nitrate ester plasticizer especially suited for use in solid rocket motor propellants that are subjected to low temperature storage and operational environments, which can reach as low as −54° C. in temperature. In order to avoid problems associated with fume-off that characterize the conventional synthesis method of making diglycerol tetranitrate, synthesis is performed in a medium including a mixed acid phase and an inert organic phase. The mixed acid phase contains, as ingredients, at least one nitronium ion source and at least one acid having sufficient strength to generate nitronium ions from the nitronium ion source. The nitronium ions in the mixed acid nitrate diglycerol to form diglycerol tetranitrate, which is then received into the organic liquid. The organic liquid, which preferably is a chlorocarbon such as dichloromethane, is insoluble with diglycerol but soluble with diglycerol tetranitrate. The inert organic phase is then treated to neutralize any acid contained in the inert organic phase, and the diglycerol tetranitrate is separated from the inert organic phase.

专利号:RU-2079303-C1
优先权日:1990-09-04
标 题 :Medicinal agent as ointment for cutaneous disease and cutaneous manifestation of immunologically mediated disease treatment and/or prophylaxis and method of its synthesis

专利号:US-11230524-B2
优先权日:2017-08-17
标题 :Myocyte enhancer factor 2 (MEF2) modulators
发明人：ZHANG JUNHU
权利人:STANDARD LLC
摘要:The present disclosure provides novel compounds capable of functioning as Myocyte Enhancer Factor 2 (MEF2) modulators, as well as compositions, pharmaceutical formulations, methods of synthesis and kits.